Willow Biosciences Inc. announced that the Board of Directors has appointed Dr. Peter Seufer-Wasserthal as Interim President and Chief Executive Officer, effective July 17, 2022, in connection with Trevor Peters' retirement as President and CEO. Mr. Peters will continue to be a Director of the Company. In addition to the above mentioned changes, Ms. Barbara Munroe, a Director of the Company, has been appointed as Lead Independent Director.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.11 CAD | 0.00% | +29.41% | +10.00% |
1st Jan change | Capi. | |
---|---|---|
+10.00% | 10.22M | |
+0.99% | 91.72B | |
0.00% | 39.44B | |
-8.52% | 34.47B | |
+65.27% | 26.7B | |
-17.37% | 15.13B | |
-5.99% | 13.27B | |
-10.69% | 11.74B | |
-47.78% | 10.54B | |
+8.09% | 9.41B |
- Stock Market
- Equities
- WLLW Stock
- News Willow Biosciences Inc.
- Willow Biosciences Inc. Appoints Dr. Peter Seufer-Wasserthal as Interim President